Navigation Links
New drug proven to tackle Type 2 Diabetes

A new drug called Rosiglitazone capable of controlling Type 2 diabetes has been given the green signal by researchers, Researchers// content that this drug is capable of reported in The Lancet ,a renounced British medical journal . Researchers content that this drug is capable of reducing Type 2 Diabetes by 60%.

The results of a 3 year long study named DREAM(for Diabetes Reduction Approaches with Medication )conducted at Royal Victoria Hospital led by endocrinologist Jean-Francois Yale have shown that in every thousand cases of “pre-diabetes” treated with Rosiglitazone,144 new cases were prevented. The drug exhibited a capability to bring down blood sugar levels to normal. This 25 million dollar study which was funded by 3 drug companies and Canadian Institutes of Health Research studied 5,000 patients recruited from over 21 countries. Canada itself has a staggering 2 million diabetics currently and is expected to cross 3 million by year 2010.

Such a breakthrough would immensely benefit individuals with a strong history of Diabetes running in the family, or were either parent or both are already known diabetics. However it has to be kept in mind that predominantly it is only a well balanced diet and regular exercise that have been proven to pay rich dividends in controlling the late onset type of diabetes, as proven in research studies. Though currently rosiglitazone is being used only as a second line treatment for diabetics, it may soon be used as a front line therapy for nearly 8% of people with high blood sugar world wide.

Rosiglitazone is still not proven in its efficacy to stall onset of Diabetes in those who fall in the high risk group or if there could be a relapse of diabetes if it is withdrawn from a patient. Nearly 2 million Canadians are diabetic. The Canadian Diabetes Association predicts that number will rise to 3 million by 2010.

It's not known yet whether the drug prevents or delays diabetes or whether i ts effects disappear once patients stop treatment.


MS
'"/>




Related medicine news :

1. TELITHROMYCIN - the proven effective new drug for cap
2. Partial-Breast Irradiation an Unproven Therapy
3. The Use of Radio Frequency Identification ( RFID) to tackle the growing menace of counterfeit drugs
4. Guidelines to tackle bird flu pandemic
5. U.S. unprepared to tackle bird flu
6. Meeting to tackle Chikungunya
7. AIDS to be tackled through Computer Games
8. Is Diabetes the Leading Cause of Kidney Failure in India
9. Diabetes and Depression often go hand-in-hand
10. Thirty minutes of work up per day reduces the risk of Diabetes
11. Diabetes on the rise
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... February 24, 2017 , ... The California State University ... academic faculty engaged in or interested in palliative care education and research. The Symposium, ... held in North County San Diego on Sept. 28 and 29, 2017, on the ...
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica Communications, ... thought leadership , media relations, social media, content marketing and SEO, is ... powered through Act-On, an intuitive marketing automation platform. , Rosica will now offer ...
(Date:2/23/2017)... ... February 23, 2017 , ... The 89th Academy Awards will ... the 2016 National Education Policy Center Bunkum Award. We invite you to enjoy our ... This year’s Bunkum winner is the Center for American Progress (CAP), for its report, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Hamlin Dental Group ... that they are sponsoring a raffle. Throughout the month of February, patients who visit ... a gift card for a dinner for two at the Cheesecake Factory. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing ... generations converge and explore the world from different perspectives. By providing a place ... to gain understanding, increase empathy, and find greater happiness. , "Our approach ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... NEW YORK , Feb. 23, 2017  Genesis ... HME Company. The announcement was made by Bill ... David Hartley and Nathan Feltman , ... of Genesis Healthcare Services, LLC. This ... nation,s largest provider of technology enabled durable medical equipment ...
(Date:2/23/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company ... the urology market, will release financial results for the ... before the market open on Thursday, March 9, 2017. ... call and webcast to discuss its financial results the ... a.m. Eastern Time (10:00 a.m. Central Time). Darin ...
(Date:2/23/2017)... REDWOOD CITY, Calif., Feb. 23, 2017 Nevro Corp. ... innovative evidence-based solutions for the treatment of chronic pain, today ... ended December 31, 2016. 2016 Accomplishment & ... the full year 2016, an increase of 228% as reported, ... million for 2016, an increase of 612% over the prior ...
Breaking Medicine Technology: